Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nowak

Showing results (711-720 of 807) with videos related to

Pageof 81
Sort By:
Neurology|January 2, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, et al.
Stem Cell Research|June 21, 2022
Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 geneJoshua S Clayton, Isabella Suleski, Christina Vo, et al.
Nature Genetics|March 21, 1998
Linkage-disequilibrium mapping without genotypingV G Cheung, J P Gregg, K J Gogolin-Ewens, et al.
Neuromuscular Disorders : NMD|September 2, 2006
Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutationAdele D'Amico, Claudio Graziano, Giuseppe Pacileo, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Human Mutation|June 30, 2009
Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1)Nigel G Laing, Danielle E Dye, Carina Wallgren-Pettersson, et al.
Plos One|October 17, 2012
Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositisArundhati Ray, Anthony A Amato, Elizabeth M Bradshaw, et al.
Annals of Internal Medicine|January 27, 2025
Guidelines International Network: Principles for Use of Artificial Intelligence in the Health Guideline EnterpriseBernardo Sousa-Pinto, Manuel Marques-Cruz, Ignacio Neumann, et al.
The American Journal of Pathology|April 4, 2009
Gab2-mediated signaling promotes melanoma metastasisBasil Horst, Sofia K Gruvberger-Saal, Benjamin D Hopkins, et al.
Genome Research|February 3, 2005
Mapping segmental and sequence variations among laboratory mice using BAC array CGHAntoine M Snijders, Norma J Nowak, Bing Huey, et al.
Pageof 81

Showing results (711-720 of 807) with videos related to

Sort By:
Pageof 81
Neurology|January 2, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, et al.
Stem Cell Research|June 21, 2022
Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 geneJoshua S Clayton, Isabella Suleski, Christina Vo, et al.
Nature Genetics|March 21, 1998
Linkage-disequilibrium mapping without genotypingV G Cheung, J P Gregg, K J Gogolin-Ewens, et al.
Neuromuscular Disorders : NMD|September 2, 2006
Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutationAdele D'Amico, Claudio Graziano, Giuseppe Pacileo, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Human Mutation|June 30, 2009
Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1)Nigel G Laing, Danielle E Dye, Carina Wallgren-Pettersson, et al.
Plos One|October 17, 2012
Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositisArundhati Ray, Anthony A Amato, Elizabeth M Bradshaw, et al.
Annals of Internal Medicine|January 27, 2025
Guidelines International Network: Principles for Use of Artificial Intelligence in the Health Guideline EnterpriseBernardo Sousa-Pinto, Manuel Marques-Cruz, Ignacio Neumann, et al.
The American Journal of Pathology|April 4, 2009
Gab2-mediated signaling promotes melanoma metastasisBasil Horst, Sofia K Gruvberger-Saal, Benjamin D Hopkins, et al.
Genome Research|February 3, 2005
Mapping segmental and sequence variations among laboratory mice using BAC array CGHAntoine M Snijders, Norma J Nowak, Bing Huey, et al.
Pageof 81